Gail Wilensky
This article was originally published in The Gray Sheet
Executive Summary
Outgoing Medicare Payment Advisory Commission Chairman plans to increase her work with Republican and Democratic lawmakers on potential legislation, following U.S. Comptroller General David Walker's May 15 announcement that she would not have her chairmanship renewed. Members of the health care lobby speculate that increasing concern on Capitol Hill over Wilensky's financial investments in health care ventures (worth an estimated $4 mil.) contributed to the decision not to renew her chairmanship. Wilensky will be replaced as MedPAC chairman by former CEO of Harvard Vanguard Medical Associates Glenn Hackbarth, who was appointed to the commission in 2000
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.